tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

XLO Stock Latest News

Xilio Therapeutics: Strategic Pivot and Promising Pipeline Drive Buy Rating
RatingsXilio Therapeutics: Strategic Pivot and Promising Pipeline Drive Buy Rating
12d ago
XLO
Promising Clinical Developments and Strong Financial Outlook Justify Buy Rating for Xilio Therapeutics
PremiumRatings
Promising Clinical Developments and Strong Financial Outlook Justify Buy Rating for Xilio Therapeutics
14d ago
XLO
Xilio Therapeutics Reports 2024 Financial Results and Pipeline Progress
PremiumCompany Announcements
Xilio Therapeutics Reports 2024 Financial Results and Pipeline Progress
14d ago
XLO
Xilio Therapeutics files $250M mixed securities shelf
PremiumThe Fly
Xilio Therapeutics files $250M mixed securities shelf
14d ago
XLO
Xilio Therapeutics reports Q4 EPS (20c) vs (64c) last year
PremiumThe Fly
Xilio Therapeutics reports Q4 EPS (20c) vs (64c) last year
15d ago
XLO
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
1M ago
XLO
ABBV
Xilio Therapeutics: Innovative TCE Platform and Strategic AbbVie Partnership Justify Buy Rating
Premium
Ratings
Xilio Therapeutics: Innovative TCE Platform and Strategic AbbVie Partnership Justify Buy Rating
1M ago
XLO
Xilio (XLO) Stock Zooms 125% Higher On Cancer Fighting Deal with AbbVie
Premium
Market News
Xilio (XLO) Stock Zooms 125% Higher On Cancer Fighting Deal with AbbVie
1M ago
XLO
ABBV
Xilio Therapeutics Partners with AbbVie for Immunotherapy Expansion
PremiumCompany Announcements
Xilio Therapeutics Partners with AbbVie for Immunotherapy Expansion
1M ago
8K
XLO
Xilio Therapeutics announces multiple masked T cell engager programs
PremiumThe Fly
Xilio Therapeutics announces multiple masked T cell engager programs
1M ago
XLO
AbbVie and Xilio Therapeutics announce collaboration
PremiumThe Fly
AbbVie and Xilio Therapeutics announce collaboration
1M ago
XLO
ABBV
Xilio Therapeutics Advances with Phase 2 Trial Data
PremiumCompany Announcements
Xilio Therapeutics Advances with Phase 2 Trial Data
2M ago
8K
XLO
Xilio reports results from ongoing Phase 2 clinical trial of vilastobart
PremiumThe FlyXilio reports results from ongoing Phase 2 clinical trial of vilastobart
2M ago
XLO
Xilio Therapeutics Secures $25M Investment from Gilead
Premium
Company Announcements
Xilio Therapeutics Secures $25M Investment from Gilead
3M ago
8K
XLO
Xilio Therapeutics to present initial Phase 2 data for XTX101 at ASCO GI
Premium
The Fly
Xilio Therapeutics to present initial Phase 2 data for XTX101 at ASCO GI
3M ago
XLO
Xilio Therapeutics appoints Caroline Hensley as CLO
PremiumThe Fly
Xilio Therapeutics appoints Caroline Hensley as CLO
3M ago
XLO
MCRB
Xilio Therapeutics Reports Q3 2024 Progress and Financials
PremiumCompany Announcements
Xilio Therapeutics Reports Q3 2024 Progress and Financials
5M ago
XLO
Xilio Therapeutics Advances Cancer Drug and Financial Outlook
PremiumCompany Announcements
Xilio Therapeutics Advances Cancer Drug and Financial Outlook
5M ago
8K
XLO
Xilio Therapeutics announces initial data from Phase 1C trial for XTX101
PremiumThe Fly
Xilio Therapeutics announces initial data from Phase 1C trial for XTX101
5M ago
XLO
Xilio Therapeutics expects cash to fund operations into Q2 of 2025
PremiumThe FlyXilio Therapeutics expects cash to fund operations into Q2 of 2025
5M ago
XLO
Xilio Therapeutics reports Q3 EPS (22c), consensus (25c)
Premium
The Fly
Xilio Therapeutics reports Q3 EPS (22c), consensus (25c)
5M ago
XLO
Xilio Therapeutics reports Q2 EPS (24c) vs (70c) last year
Premium
The Fly
Xilio Therapeutics reports Q2 EPS (24c) vs (70c) last year
8M ago
XLO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >